ClinicalTrials.govcontrolled

Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.

ClinicalTrials.gov study NCT02598297. IPD Sharing: YES. Countries: 25. Publications: 0.

ShareScore

32/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 16
Harmonization: 8
Access: 4
Reuse readiness: 0
Engagement: 4

Topics

clinical trial NIH ClinicalTrials.gov

Dataset details

Repository: ClinicalTrials.gov
Published: February 11, 2026
License: IPD-YES
DOI: clinicaltrials.gov/NCT02598297

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CV How the NIH biosketch works